Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma-Reference-Cited by-同舟云学术

Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma

Published:2017-01-27 Issue:4 Volume:241 Page:522-533
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Herfs Michael¹,Longuespée Rémi²,Quick Charles M³,Roncarati Patrick¹,Suarez-Carmona Meggy¹,Hubert Pascale¹,Lebeau Alizée¹,Bruyere Diane¹,Mazzucchelli Gabriel²,Smargiasso Nicolas²,Baiwir Dominique²⁴,Lai Keith³,Dunn Andrew³,Obregon Fabiola³,Yang Eric J⁵,Pauw Edwin De²,Crum Christopher P⁵,Delvenne Philippe¹

Affiliation:

1. Laboratory of Experimental Pathology, GIGA-Cancer; University of Liège; Liège Belgium

2. Mass Spectrometry Laboratory, Systems Biology and Chemical Biology, GIGA-Research; University of Liège; Liège Belgium

3. Department of Pathology; University of Arkansas for Medical Sciences; Little Rock AR USA

4. GIGA Proteomic Facility; University of Liège; Liège Belgium

5. Department of Pathology, Division of Women's and Perinatal Pathology, Brigham and Women's Hospital; Harvard Medical School; Boston MA USA

Funder

Belgian Fund for Medical Scientific Research (FNRS/Televie)

Centre Anti-Cancereux près l'Université de Liège

Fonds Léon Frédéricq

Seventh Framework Program for Research and Technological Development

Publisher